Lycopene-rich Juice Intervention to Reduce Inflammatory Markers Among Adults With Obesity
NCT ID: NCT07120035
Last Updated: 2025-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2024-03-27
2024-09-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining Validity and Sensitivity of Pressure-Mediated Reflection Spectroscopy
NCT04056624
Effects of Phytonutrients on Vascular Health and Skin in Obese Males
NCT03496584
Plant Pigments for Human Health: Impact of Lycopene and Anthocyanins on Bioefficacy of Provitamin A Carotenoids From Carrots
NCT05319548
Effects of Anthocyanin on Skin Health and Markers of Cardiovascular Disease Risk
NCT00574574
Tomato Juice for Health Study
NCT03783013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lycopene-rich juice group
Lycopene-rich juice
We sought to deliver 8400 µg of lycopene per day, and so participants were asked to drink approximately 4 fluid ounces per day of the tomato-based, lycopene-rich juice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lycopene-rich juice
We sought to deliver 8400 µg of lycopene per day, and so participants were asked to drink approximately 4 fluid ounces per day of the tomato-based, lycopene-rich juice.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 years of age
* Able to speak, read, and understand English
* Willing and able to drive to the research office, have a small amount of blood drawn by a trained phlebotomist, complete a questionnaire about health, demographics, and your food consumption, have height, weight, body fat, and skin tone measured, and have your skin carotenoids measured using the Veggie Meter.
* Willing to maintain your usual levels of exercise and diet.
* Willing to consume juice daily for the study duration, 3 weeks. We will provide this juice to you.
Exclusion Criteria
* Under 18 years of age
* Not able to speak, read, and understand English
* Not willing to drink the test juice daily
* Unable to get to the research office for the baseline and follow-up measures
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baylor College of Medicine
OTHER
University of Minnesota
OTHER
East Carolina University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephanie Pitts, PhD
Role: PRINCIPAL_INVESTIGATOR
East Carolina University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
East Carolina Diabetes and Obesity Institute
Greenville, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UMCIRB 23-002535
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.